AYTU BIOPHARMA, INC — Director's Dealing 2016

Aug 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AYTU BIOSCIENCE, INC (AYTU)
CIK: 0001385818
Period of Report: 2016-08-02

Reporting Person: Gould Gregory A (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-02	Common Stock	A	41899	$0.00	Acquired	206899	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option Grant	$3.23	2025-11-11	Common Stock (20834)	20834	Direct
Employee Stock Option Grant	$3.23	2026-07-07	Common Stock (25000)	25000	Direct

Footnotes

F1: These shares were granted as a bonus for performance in August 2016.

F2: Of these shares, 165,000 are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations.

F3: These options are 100% vested.

F4: 33.3% vests on the one year, two year and three year anniversary of the date of grant, subject to the Grantee's continued service as an employee on such dates.